Diagnosis and Treatment of Leprosy Reactions in Integrated Services - The Patients' Perspective in Nepal

PLoS Neglected Tropical Diseases

Volumn 7, Issue 3, 2013, Pages

  Raffe, Sonia F ^a   Thapa, Min ^b   Khadge, Saraswoti ^b   Tamang, Krishna ^c   Hagge, Deanna ^b   Lockwood, Diana N J ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b Anandaban Leprosy Hospital   (Nepal)

^c Lalgadh Hospital   (Nepal)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; ERYTHEMA NODOSUM LEPROSUM; EYE PAIN; FACE PAIN; FEMALE; FEVER; FOLLOW UP; HEALTH CARE ACCESS; HEALTH CARE PERSONNEL; HEALTH SERVICE; HUMAN; INTERVIEW; KNEE PAIN; LEPROSY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MYALGIA; NEPAL; PATIENT CARE; REVERSAL REACTION; SKIN ALLERGY; SKIN DEFECT; SKIN NODULE;

EID: 84876006539     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002089     Document Type: Article

References (17)

1. Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, et al. (2006) The Continuing Challenges of Leprosy. Clin Microbiol Rev 19: 338-381 doi:10.1128/CMR.19.2.338-381.2006.
2. Saunderson P (2002) How to Recognise and Manage Leprosy Reactions. International Federation of Anti-Leprosy Associations. 52 pp.
3. Britton WJ, Lockwood DNJ, (2004) Leprosy. Lancet 363: 1209-1219 doi:10.1016/S0140-6736(04)15952-7.
4. Kahawita IP, Walker SL, Lockwood DNJ, (2008) Leprosy type 1 reactions and erythema nodosum leprosum. Anais Brasileiros de Dermatologia 83: 75-82.
5. Bryceson A, Pfaltzgraff RE, editors (1990) Leprosy. 3rd edition. Edinburgh: Churchill Livingstone.
6. Van Veen N, Nicholls PG, Smith W, Richardus JH, (2007) Corticosteroids for treating nerve damage in leprosy. (A Cochrane review). Lepr Rev 79: 361-71 doi:10.1002/14651858.CD005491.pub2.
7. Sundar Rao P, Sugamaran D, Richard J, Smith W, (2006) Multi-centre, double blind, randomized trial of three steroid regimens in the treatment of type-1 reactions in leprosy. Lepr Rev 77: 25.
8. Naafs B, (2006) Treatment of Leprosy: science or politics? Trop Med Int Health 11: 268-278 doi:10.1111/j.1365-3156.2006.01561.x.
9. Pocaterra L, Jain S, Reddy R, Muzaffarullah S, Torres O, et al. (2006) Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India. Am J Trop Med Hyg 74: 868-879.
10. Leprosy WECO (1998) WHO Expert Committee on Leprosy. 7th edition. Geneva: World Health Organization.
11. Worldbank (2007) Nepal: Transport At Glance. siteresourcesworldbankorg: 1-2. Available: http://siteresources.worldbank.org/INTSARREGTOPTRANSPORT/1812598-1130163732725/21884244/Nepal_Transport_At_Glance_2007_update_2008.pdf. Accessed 2 April 2012.
12. Jain MC, (2008) Leprosy Scenario in Nepal. J Nepal Med Assoc 47: 259-263.
13. World Health Organization (2009) Enhanced Global Strategy for Further Reducing the Disease Burden due to Leprosy (Plan Period: 2011-2015). World Health Organization.
14. Pope C, Ziebland S, Mays N, (2000) Analysing qualitative data. BMJ 320: 114-116.
15. Richardus JH, Withington SG, Anderson AM, Croft RP, Nicholls PG, et al. (2003) Adverse events of standardized regimens of corticosteroids for prophylaxis and treatment of nerve function impairment in leprosy: results from the "TRIPOD" trials. Lepr Rev 74: 319-327.
16. Wijesinghe PR, Settinayake S, (2005) An analysis of the pattern of detection of leprosy patients by institutions in the general health services in Sri Lanka after the integration of leprosy services into general health services. Lepr Rev 76: 296-304.
17. Siddiqui MR, Velidi NR, Pati S, Rath N, Kanungo AK, et al. (2009) Integration of Leprosy Elimination into Primary Health Care in Orissa, India. PLoS ONE 4: e8351 doi:10.1371/journal.pone.0008351.